HALIFAX, NS / ACCESSWIRE / / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for the quarter ended ...
The Nova Scotia-based firm's Multiplo Rapid TP/HIV Test is used to detect antibodies to HIV 1/2 and syphilis in a finger prick blood sample.
GlobalData on MSN9d
Health Canada approves MedMira’s rapid test for HIV and syphilisThe test enables healthcare professionals to identify HIV-1/2 and syphilis antibodies from a single finger prick sample.
Hosted on MSN4d
MedMira Reports Progress and Market ExpansionMedmira (TSE:MIR) has released an update. MedMira Inc. has reported significant progress in its regulatory and clinical activities, including ...
11d
HALIFAX, NS / ACCESSWIRE / December 24, 2024 / MedMira Inc. (MedMira) (TSXV:MIR) announced today that it has received today, ...
During Q1 FY2025, MedMira has been continuing its regulatory work and clinical trials for its Reveal® G4 HIV-1/2 rapid test CLIA-waiver and with it made substantial progress on its FDA ...
all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter MedMira Inc. has reported significant progress in its regulatory ...
Medmira (TSE:MIR) has released an update. Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback